Find your next paid study

The Foundation for Orthopaedics and Regenerative MedicineNCT05147688

~$150 – $3,000

Actual pay is set by the research site.

Phase 2

A Phase 2b / 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects With End Stage Kidney Disease Undergoing Dialysis

This is a two-part, phase 2b and phase 3 combined prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1: Phase …

End Stage Kidney Disease

~$75 – $3,000

Actual pay is set by the research site.

CSL BehringNCT05485961

Thermogenic Responses to Fasting and Overfeeding in Women: a Potential Mechanism Contributing to Postmenopausal Weight Gain

This study plans to learn more about why menopause increases the risk of weight gain. During and after menopause, women are prone to increased weight gain. The…

Obesity

University of Colorado, DenverNCT06610162

Actual pay is set by the research site.

Vaccine ConfidenceAdolescent VaccinationVaccine Uptake

Assessment of Adolescent and Young Adult Vaccine Confidence and Missed Opportunities for Vaccination in the Mountain West (VACCINE CONFIDENCE - WEST): A Randomized Tailored Vaccine Messaging Intervention

his study will evaluate whether tailored vaccine messaging improves vaccination-related outcomes among parents and caregivers of adolescents. Participants will…

University of UtahNCT07878442

Actual pay is set by the research site.

SepsisDiagnosisEmergencies

The Right Call: Implementing a Sepsis Diagnostic Safety Toolkit in a Pediatric Transfer Call Center to Improve Diagnosis of Children in General Emergency Settings

Sepsis is a leading cause of death in children, and an early diagnosis that improves outcomes is less likely in children who are treated in general Emergency D…

University of Colorado, DenverNCT07051668

Actual pay is set by the research site.

Phase 4

A Multicentre, Open-label, Randomised Phase IV Study to Investigate Acalabrutinib Monotherapy Compared to Investigator's Choice of Treatment in Adults (> 18 Years) With Chronic Lymphocytic Leukaemia and Moderate to Severe Cardiac Impairment

This will be a global Phase IV, open-label, randomised study to evaluate the safety and tolerability of acalabrutinib (monotherapy, 100 mg orally \[po\], twice…

Chronic Lymphocytic LeukaemiaModerate to Severe Cardiac Impairment

Diabetes Mellitus, Type 2

~$25 – $1,500

Actual pay is set by the research site.

AstraZenecaNCT06651970

Phase 3

Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes

The goal of this study is to learn how GLP-1 receptor agonist therapy affects muscle and bone health in older females over age 65 with type 2 diabetes. The ma…

Emory UniversityNCT07428746

~$50 – $1,500

Actual pay is set by the research site.

Phase 3

A Randomised, Double-blind, Placebo-controlled, Phase III Study of Adjuvant Saruparib (AZD5305) in Patients With BRCAm Localised High-Risk Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy (EvoPAR-Prostate02).

The purpose of the study is to demonstrate superiority of Saruparib (AZD5305) relative to placebo added to a standard radiation therapy (RT) + androgen depriva…

Prostate Cancer

HypophosphatemiaRicketsHypercalciuria+2 more

~$50 – $2,250

Actual pay is set by the research site.

AstraZenecaNCT06952803

Phase 1

The Impact of Phosphate Metabolism on Healthy Aging

Determine the association between duration and dose of chronic conventional therapy with Pi and renal (nephrocalcinosis/nephrolithiasis), vascular (endothelial…

Yale UniversityNCT03771105

~$150 – $3,000

Actual pay is set by the research site.

Retina BioBank: Retina Biomarkers for a Deeper Understanding of Vitreoretinal and Systemic Diseases

The RBBK study is a non-interventional, prospective study that will characterize disease state biomarker levels from aqueous humor, vitreous humor, intraoperat…

Other Retinal DisordersRetinal DiseaseRetinal Vascular Disorder

Greater Houston Retina ResearchNCT06796673

~$10 – $1,125

Actual pay is set by the research site.

Handheld Point of Care Electro-Diagnostic Device

There are currently several products offering POC EEG, intended to be deployed on each patient individually and continuously. The investigators propose studyin…

Neurologic Findings

Indiana UniversityNCT07223827

Actual pay is set by the research site.

This is a Human Analytics Longitudinal Observational (HALO) Study. A Phase I Study to Analyze All Available Biomarkers and Determinants of Health to Increase Diagnostic Accuracy While Reducing the Time to Diagnosis of Disease.

Discover, optimize, standardize, and validate clinical-trial measures and biomarkers used to diagnose and differentiate cardiovascular, oncologic, neurologic, …

Cardiovascular DiseasesCancerDementia+1 more